Pulmonary neuroendocrine tumors: treatment need and new treatment options
W Engel-Riedel, J Zimmermann, C Ludwig, E Stoelben, M Thomas, M Serke, W Eberhardt, S Herbertz, C Hosius, J Stieglmaier · Pneumologie · 2011 · Heft 03
Bibliografische Angaben
Zusammenfassung
Objective: Neuroendocrine tumors (NET) of the lung can be divided in typical carcinoid (TC), atypical carcinoid (AT), large cell neuroendocrine carcinoma (LCNEC) and small cell lung carcinoma (SCLC). Carcinoids and LCNEC are rare tumors with a reported prevalence of approximately 3% among surgically resected lung cancers. There is only little information on the prevalence of lung NET and no treatment standards exist. Targeted therapy such as mTOR inhibitors is discussed as promising approach. Here we present data from one institution and new treatment options in clinical trials. Patients and Methods: Retrospecti…
